Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Favre

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Transplantation and Cellular Therapy|March 9, 2024
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP TrialArcangelo Prete, Edoardo Lanino, Francesco Saglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma RegistryRiccardo Haupt, Alberto Garaventa, Claudio Gambini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in ItalyChiara Messina, Marco Zecca, Franca Fagioli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2015
The prognostic value of biological markers in paediatric Hodgkin lymphomaPiero Farruggia, Giuseppe Puccio, Alessandra Sala, et al.
Leukemia & Lymphoma|October 11, 2018
Classical pediatric Hodgkin lymphoma in very young patients: the Italian experiencePiero Farruggia, Giuseppe Puccio, Francesco Locatelli, et al.
Blood|October 24, 2018
Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemiaAlice Bertaina, Marco Zecca, Barbara Buldini, et al.
Haematologica|January 13, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL studyMarco Cerrano, Massimiliano Bonifacio, Matteo Olivi, et al.
Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy RegistryFrancesca Bagnasco, Silvia Caruso, Anita Andreano, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Transplantation and Cellular Therapy|March 9, 2024
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP TrialArcangelo Prete, Edoardo Lanino, Francesco Saglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma RegistryRiccardo Haupt, Alberto Garaventa, Claudio Gambini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in ItalyChiara Messina, Marco Zecca, Franca Fagioli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2015
The prognostic value of biological markers in paediatric Hodgkin lymphomaPiero Farruggia, Giuseppe Puccio, Alessandra Sala, et al.
Leukemia & Lymphoma|October 11, 2018
Classical pediatric Hodgkin lymphoma in very young patients: the Italian experiencePiero Farruggia, Giuseppe Puccio, Francesco Locatelli, et al.
Blood|October 24, 2018
Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemiaAlice Bertaina, Marco Zecca, Barbara Buldini, et al.
Haematologica|January 13, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL studyMarco Cerrano, Massimiliano Bonifacio, Matteo Olivi, et al.
Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy RegistryFrancesca Bagnasco, Silvia Caruso, Anita Andreano, et al.
Pageof 8